On the antiserotonin activity of 6-acetamido-3(3-(4-phenyl-1-piperazinyl)-propyl)-284(1h,3h)-quinazolinedione-maleate (MA 1420).
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002714:Chlorisondamine / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000188:drug therapy; D005260:Female; D006168:Guinea Pigs; D008168:Lung / Q000187:drug effects; D008784:Methysergide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012702:Serotonin Antagonists; D014599:Uterus / Q000187:drug effects
D010879:Piperazines; D011799:Quinazolines; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D002714:Chlorisondamine; D008784:Methysergide